01-02-2024 | Polymyalgia Arteritica | Case report
Catequentinib/nivolumab
Progressive maculopapular rash, pruritus and lack of drug effect
Published in: Reactions Weekly | Issue 1/2024
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event